Karyopharm Therapeutics Inc.'s next confirmed earnings release is scheduled for November 16, 2026.
| Earnings Date | 11/16/2026 |
As of the close on November 16, 2026, Karyopharm Therapeutics Inc.'s stock has declined approximately 99.50% over the past 52 weeks. The 50-day moving average sits at 0.85, while the 200-day moving average is 5.71.
| 52-Week Price Change | -99.50% |
| 50-Day Moving Average | 0.85 |
| 200-Day Moving Average | 5.71 |
Karyopharm Therapeutics Inc.'s most recent stock split took place on February 26, 2025 with a 15:1 split ratio.
| Last Split Date | 2/26/2025 |
| Split Ratio | 15:1 |